Clinical Trials
A Look at Driving Simulation Clinical Trials
Participant Retention Strategies in Phase I Clinical Trials
In this article, we explore key participant retention strategies in Phase I clinical trials.
First-In-Human and Proof-of-Concept Trials
![]() |
|
Over the past decades, Altasciences has designed and conducted over 200 first-in-human and stand-alone proof-of-concept studies. Our comprehensive, full service, early development offerings and experience help you develop sound strategies and allow you to minimize the time taken to make critical go/no-go decisions by harmonizing our clinical pharmacology facilities, biomarker capabilities, PK/PD analysis expertise, and program knowledge. |
|
![]() |
|
![]() |
NDA-Enabling Study Guide
![]() |
|
Altasciences' specialists apply their decades of experience in designing, conducting, analyzing, and reporting on trials for regulatory submissions, across the spectrum of therapeutic areas. Unclear as to which studies may be required? Download our complimentary fact sheet or click below to learn more about the requirements for each study type. |
|
![]() |
Safety Tolerability and Pharmacokinetics of GIC-1001 Following Multiple Ascending Doses Administrations Through an Adaptive First-in-Human Study in Healthy Volunteers
Cognitive Performance and Psychedelic Effects Following Single and Multiple Ascending Doses of a New Cannabis Formulation
Microsampling - Making a Difference in Drug Development
Microsampling volume
Blood microsampling is a less invasive and simplified alternative to traditional venipuncture, and provides significant ad
Altasciences Fills Need of Leading Cancer Therapeutic Drug Developer
Microsampling Benefits
Choosing the Right CRO for Your Clinical Trial Monitoring
![]() |
|
At Altasciences, we understand your clinical trials are unique and require careful management. As part of our partnership with you, our highly experienced CRAs offer top quality monitoring, through agile and flexible processes and transparent communication. We are up to date with all required trainings, and remain abreast of current legislations, techniques, and technologies. For more information on Altasciences' monitoring capabilities, contact one of our experienced CRA team members. |